Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001214659-23-001862
Filing Date
2023-02-09
Accepted
2023-02-09 09:19:28
Documents
1
Group Members
RICHARD MAGIDES

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 2 s126231sc13ga2.htm SC 13G/A 53323
  Complete submission text file 0001214659-23-001862.txt   54982
Mailing Address 245 HAMMERSMITH ROAD, 3RD FLOOR LONDON X0 W6 8PW
Business Address 245 HAMMERSMITH ROAD, 3RD FLOOR LONDON X0 W6 8PW 011-44-0-203-3846700
Orchard Therapeutics plc (Subject) CIK: 0001748907 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-90710 | Film No.: 23601577
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 65 CHULIA STREET #45-04 OCBC CENTRE SINGAPORE U0 049513
Business Address 65 CHULIA STREET #45-04 OCBC CENTRE SINGAPORE U0 049513 6566351950
Zentree Investments Ltd (Filed by) CIK: 0001946012 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 0331
Type: SC 13G/A